[NFA] U.S. health officials tried to reassure the public Wednesday after AstraZeneca suspended global trials of its experimental coronavirus vaccine due to an unexplained illness in a participant in Britain, casting doubt on prospects for an early rollout.
Lisa Bernhard produced this report.